CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-05 | NEIL GARRY ARTHUR CEO and Chairman of the Board | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2022-10-05 | Sullivan Christopher Ryan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-09-30 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) | +605 | 605 | ||
| 2022-09-30 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +3,080 | 3,080 | ||
| 2022-09-30 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +3,747 | 3,747 | ||
| 2022-06-30 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +26,837 | 26,837 | ||
| 2022-06-30 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +44,115 | 44,115 | ||
| 2022-06-30 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) | +4,338 | 4,338 | ||
| 2022-06-14 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-06-14 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-06-14 | Chan Mitchell Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-06-14 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-03-31 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +18,468 | 18,468 | ||
| 2022-03-31 | Miller Joseph M Director | Grant or award · Stock Option (Right to Buy) | +20,239 | 20,239 | ||
| 2022-03-31 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +30,359 | 30,359 | ||
| 2022-03-31 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) | +2,985 | 2,985 | ||
| 2022-03-14 | ARMISTICE CAPITAL, LLC Director | Purchase | +100,000 | $0.65 | $65K | 47,576,000 |
| 2022-03-11 | ARMISTICE CAPITAL, LLC Director | Purchase | +100,000 | $0.69 | $69K | 47,476,000 |
| 2022-03-10 | ARMISTICE CAPITAL, LLC Director | Purchase | +26,000 | $0.70 | $18K | 47,376,000 |
| 2022-03-08 | Sullivan Christopher Ryan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 |
Page 14 of 25 · 500 trades